Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Glaukos Corp (NY: GKOS)
60.43 USD  -2.93 (-4.62%)
Official Closing Price  /  Updated: 5:01 PM EST, Dec 18, 2018  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 695,200
Open 64.13
Bid (Size) 60.37 (15)
Ask (Size) 60.30 (10)
Prev. Close 63.36
Today's Range 59.83 - 64.13
52wk Range 25.25 - 70.91
Shares Outstanding 34,906,021
Dividend Yield N/A
Performance
YTD
+123.15%
+123.15%
1 Month
+6.84%
+6.84%
3 Month
-3.06%
-3.06%
6 Month
+39.11%
+39.11%
1 Year
+128.99%
+128.99%
Top News
More News
Consolidated Research: 2018 Summary Expectations for The Hackett Group, Green Plains, Malibu Boats, Hawaiian Electric Industries, Iridium Communications, and Glaukos — Fundamental Analysis, Key Perfor
In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of The Hackett Group, Inc.... Read More
from GlobeNewswire News Releases
Glaukos iStent inject® Implantation with Concomitant Cataract Surgery Provides Sustained Reduction in IOP and Medication Burden, According to New Study
Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical... Read More
from Business Wire News Releases
More News
Read More
Glaukos Announces Participation in Piper Jaffray Healthcare Conference
from Business Wire News Releases
Glaukos Corporation Announces Third Quarter 2018 Financial Results
from Business Wire News Releases
Detailed Research: Economic Perspectives on DDR, Acuity Brands, Douglas Emmett, Glaukos, US Ecology, and Lear — What Drives Growth in Today's Competitive Landscape
from GlobeNewswire News Releases
Glaukos Technologies Featured in Presentations at 2018 American Academy of Ophthalmology Conference
from Business Wire News Releases
Glaukos Corporation to Release Third Quarter 2018 Financial Results after Market Close on November 7
from Business Wire News Releases
Crown Laboratories Acquires Bellus Medical
from Business Wire News Releases
Peek Under The Hood: IHI Has 16% Upside
category ETFs
from ETF Channel
Multiple Surgeon Presentations to Showcase Glaukos Products at 2018 European Society of Cataract and Refractive Surgeons Congress
from Business Wire News Releases
Commit To Purchase Glaukos Corp At $22.50, Earn 3.1% Annualized Using Options
category Stocks
from Market News Video
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.